GlassScriptPhysician profile
Saritha Aleti
NPI 1295965507
$4,706.62
in general payments reported to CMS, 2019-2025
45 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $911 · 2020: $985 · 2021: $1,207 · 2022: $311 · 2023: $574 · 2024: $346 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $492.70 | 2019-2025 | Ozempic |
| Mannkind Corporation | $482.09 | 2021-2022 | |
| Lilly USA, LLC | $399.00 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Corcept Therapeutics | $392.80 | 2019-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $369.97 | 2019-2022 | |
| Amgen INC. | $216.27 | 2019-2025 | Tepezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.10 | 2019-2023 | Trijardy Xr, Jardiance, Synjardy |
| Radius Health, INC. | $167.99 | 2019-2023 | Tymlos |
| Abbvie INC. | $155.56 | 2019-2021 | |
| Insulet Corporation | $148.26 | 2019-2025 | Omnipod |
| Abbott Laboratories | $127.31 | 2020-2023 | Freestyle Libre 3 |
| Amneal Pharmaceuticals LLC | $125.68 | 2019-2024 | Unithroid |
| Companion Medical, INC. | $121.00 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $104.54 | 2019-2021 | |
| Silk Road Medical, INC. | $97.31 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saritha Aleti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.